Koyfin Home > Directory > Health Care > Aptinyx Inc

Aptinyx Inc Price Chart APTX

Historical daily share price chart and data for Aptinyx Inc since 2018 adjusted for splits and dividends. The latest closing price for Aptinyx Inc as of October 11, 2019 is $3.09.
  • In 2019 the stock opened at $16.46 and closed at $3.09 for a loss of -433% YTD.
  • In 2018 the stock opened at $17.40 and closed at $16.54 for a loss of -5%.
View Chart On Koyfin

Aptinyx Inc Summary

Stock Symbol: APTX

Aptinyx Inc Company Info

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase I clinical study for the treatment of Parkinson’s disease cognitive impairment. The company has a research collaboration agreement with Allergan plc to develop a compound for the treatment of major depressive disorder. Aptinyx Inc. was founded in 2015 and is headquartered in Evanston, Illinois.
Market Cap
104m
Dividend Yield
0 %
Beta vs SPX
0.51
Short Interest
58.6 %
30D Volatility
38.93
Hedge Fund Held
0 %
Competitors

Last 10 Days of APTX Prices

10/11/2019$3.09
10/10/2019$3.11
10/09/2019$3.08
10/08/2019$3.20
10/07/2019$3.24
10/04/2019$3.28
10/03/2019$3.29
10/02/2019$3.27
10/01/2019$3.37
09/30/2019$3.49